Tri Locum Partners LP Tg Therapeutics, Inc. Transaction History

Tri Locum Partners LP

  • $374 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$5.01 - $11.83 $1.45 Million - $3.41 Million
288,462 New
288,462 $3.41 Million
Q2 2021

Aug 16, 2021
SELL
$32.5 - $48.96 $4.83 Million - $7.28 Million
-148,620 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$41.61 - $54.3 $3.27 Million - $4.27 Million
78,688 Added 112.52%
148,620 $7.16 Million
Q4 2020

Feb 16, 2021
BUY
$25.27 - $54.9 $1.77 Million - $3.84 Million
69,932 New
69,932 $3.64 Million

Others Institutions Holding TGTX

# of Institutions
338
Shares Held
88.3M
Call Options Held
2.35M
Put Options Held
1.7M
View Full List

About TG THERAPEUTICS, INC.

TGTX Quotes by TradingView
  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $4.29B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Tri Locum Partners LP Portfolio

Follow Tri Locum Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tri Locum Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Tri Locum Partners LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email